Not exact matches
The continuing probe of the diverted funds meant for arms deal during the former
administration took another level following the arrest of the immediate
past Chief of Air Staff, Adesola Amosu
by the Economic and Financial Crime Commission (EFCC).
Taking that concept into biomedical research has yielded a breakthrough: This
past May the mTOR inhibitor everolimus was approved
by the U.S. Food and Drug
Administration for the treatment of advanced pNET, the first drug in this class approved for this disease.
I think one of the most encouraging developments in the
past year are the actions
by leading corporations to
take climate change seriously — more seriously than the current
administration in Washington.